MSPrebiotic Potato RS2: Product-Specific Resistant Starch Trials

MSPrebiotic is a potato-derived resistant starch type 2 (RS2) powder. Unlike many supplement ingredients that rely entirely on generic fiber literature, this product has the unusual advantage of product-specific randomized human trials.

That makes it one of the more evidence-traceable resistant-starch products in the catalog.

What the microbiome trial found

In a randomized, double-blind placebo-controlled study, middle-aged adults and adults age 70+ consumed 30 g/day MSPrebiotic for 12 weeks.

Compared with placebo, Bifidobacterium increased significantly in both age groups. Older adults also showed a small but significant increase in fecal butyrate.

That is a stronger evidence bridge than saying “resistant starch feeds good bacteria” in the abstract: the named product itself was tested.

What the metabolic trial found

A companion randomized analysis examined glucose, insulin and insulin resistance. At the same 30 g/day dose, older adults showed significant time-related improvements in glucose, insulin and HOMA-IR compared with placebo.

Those effects were not seen in the middle-aged group.

Prediabetes and diabetes were exclusion criteria. The study therefore does not justify presenting MSPrebiotic as a diabetes treatment.

Current retail context

The current product information describes a 10 g scoop providing 7 g insoluble fiber. The major clinical protocol used 30 g/day of product, equivalent to roughly three such scoops.

That gap matters. A consumer taking a small spoonful should not assume they are reproducing the clinical trial.

The manufacturer also advises mixing the raw RS2 into cool foods or drinks below about 60°C. Heating can change starch structure and therefore the amount that remains resistant to digestion.

Resistant starch is not one interchangeable ingredient

RS1, RS2, RS3 and chemically modified RS4 differ in structure and food context. Evidence from potato RS2 should not automatically be assigned to cooked-and-cooled rice, high-amylose maize starch or a generic potato-starch product whose resistant-starch content is unknown.

Best fit and limitations

MSPrebiotic is particularly useful for shoppers who care about:

• product-specific human trial traceability;
• a slower-fermenting starch substrate rather than FOS/inulin;
• direct microbiota measurements over a multi-week intervention.

Its limitations are equally important: the studied dose is large, the metabolic findings were age-subgroup specific, and availability is more limited than mass-market US fiber products.

Compare it with other prebiotic substrate families, including Fibersol-2 resistant maltodextrin, acacia, PHGG, XOS and HMOs.